Histone deacetylase inhibitors promote the expression ofATP2A3gene in breast cancer cell lines
- 1 September 2015
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 55 (10) , 1477-1485
Abstract
Recent studies have shown that expression of Sarco(endo)plasmic Reticulum Ca2+‐ATPase 2 (SERCA2) is decreased in oral cancer; whereas expression of SERCA3 is considerably decreased or absent in human colon, gastric, breast, and lung cancers. The ATP2A2 and ATP2A3 genes encode SERCA2 and SERCA3 isoforms, respectively. Promoter methylation on CpG islands was responsible for the repression of ATP2A2 gene in human oral cancer samples. On the other hand, histone deacetylase inhibitors (HDACi) up‐regulate ATP2A3 expression in gastric, colon, and lung cancer cells in culture, however, the molecular mechanism is unknown. In this study, we investigate whether HDACi and DNA methylation regulate ATP2A2 and ATP2A3 expression in human breast cancer cell lines. Results show a marked induction of SERCA3a and pan‐SERCA3 mRNA expression in human MCF‐7 and MDA‐MB‐231 cells treated with sodium butyrate (NaB) or trichostatin A (TSA); whereas SERCA2b mRNA expression did not change significantly. ChIP assays show that NaB or TSA treatment of MDA‐MB‐231 cells increases H3K9 acetylation on ATP2A3 promoter. NaB also decreases H3K9 trimethylation; suggesting that these modifications stimulate ATP2A3 gene expression, through a chromatin remodeling mechanism. In contrast, NaB or TSA do not increase H3K9‐acetylation of ATP2A2 proximal promoter. In addition, treatment with 5‐aza‐2′‐deoxycytidine did not affect SERCA2b and SERCA3a expression, suggesting that promoter methylation status does not alter their expression in these cell lines. We propose that alteration of SERCA2b/SERCA3a isoform expression ratio could affect calcium management within the cell, and thus, the cellular pathways regulated by calcium could be compromised, such as cellular proliferation or apoptosis.Keywords
Funding Information
- CONACyT (223272)
- PROMEP (PTC-270)
- PAPIIT-DGAPA-UNAM (IN213613)
This publication has 40 references indexed in Scilit:
- Endoplasmic Reticulum Calcium Pumps and Cancer Cell DifferentiationBiomolecules, 2012
- Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cellsMolecular Cancer, 2010
- Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to trichostatin A and 1α,25-dihydroxyvitamin D 3Nucleic Acids Research, 2007
- Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancersBreast Cancer Research and Treatment, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- Restoration of Tamoxifen Sensitivity in Estrogen Receptor–Negative Breast Cancer Cells: Tamoxifen-Bound Reactivated ER Recruits Distinctive Corepressor ComplexesCancer Research, 2006
- Calcium signalling: dynamics, homeostasis and remodellingNature Reviews Molecular Cell Biology, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Signal Transduction Pathways in ApoptosisStem Cells, 1996
- The sarco(endo)plasmic reticulum Ca2+‐ATPase mRNA isoform, SERCA 3, is expressed in endothelial and epithelial cells in various organsFEBS Letters, 1993